A sensitive, rapid and specific determination of midazolam in human plasma and saliva by liquid chromatography/electrospray mass spectrometry

Rapid Communications in Mass Spectrometry

Volumn 18, Issue 24, 2004, Pages 2976-2982

  Quintela, Oscar ^a   Cruz, Angelines ^a   Concheiro, Marta ^a   De Castro, Ana ^a   López Rivadulla, Manuel ^a  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANESTHETICS; BODY FLUIDS; LIQUID CHROMATOGRAPHY; PATIENT TREATMENT;

BENZODIAZEPINES; BIOLOGICAL SAMPLES; ELECTROSPRAY MASS SPECTROMETRY; HUMAN PLASMAS; HUMAN SALIVA; INTERNAL STANDARDS; LIQUID CHROMATOGRAPHY ELECTROSPRAY; MIDAZOLAM; QUANTITATIVE DETERMINATIONS; SELECTIVE LIQUID CHROMATOGRAPHY;

MASS SPECTROMETRY;

DIAZEPAM; MIDAZOLAM;

ANESTHESIA; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG MEGADOSE; DRUG MONITORING; DRUG SALIVA LEVEL; ELECTROSPRAY MASS SPECTROMETRY; HUMAN; HUMAN TISSUE; LIQUID CHROMATOGRAPHY; SENSITIVITY AND SPECIFICITY; STANDARD; VALIDATION PROCESS;

EID: 10844242068     PISSN: 09514198     EISSN: None     Source Type: Journal    
DOI: 10.1002/rcm.1719     Document Type: Article

References (27)

1. Nordt SP, Clark RK J. Emerg. Med. 1997; 15: 357.
2. Malinovsky JM, Populaire C, Cozian A, Lepage J-Y, Lejus C. Anaesthesia 1995; 50: 351.
3. Marshall J, Rodarte A, Blumer J, Khoo KC, Akbari B, Kearns G. J. Clin. Pharmacol. 2000; 40: 578.
4. Kintz P, Samyn N. Ther. Drug Monit. 2002; 24: 239.
5. Kaufman E, Lamster IB. Crit. Rev. Oral Biol. Med. 2002; 13: 197.
6. Cone EJ. Ann. N. Y. Acad. Sci. 1993; 694: 91.
7. Lehmann B, Boulieu R. J. Chromatogr. B 1995; 674: 138.
8. Lee TC, Charles B. Biomed. Chromatogr. 1996; 10: 65.
9. Carrillo JA, Ramos SI, Agundez JAG, Martinez C, Benitez J. Ther. Drug Monit. 1998; 20: 319.
10. Eeckhoudt SL, Desager JP, Horsmans Y, De Winne AJ, Verbeeck RK. J. Chromatogr. B 1998; 710: 165.
11. De Kroon IFI, Langendijk PNJ, De Goede PNFC. J. Chromatogr. 1989; 491: 107.
12. Fisher LE, Perch S, Bonfiglio MF, Geers SM. J. Chromatogr. B 1995; 665: 217.
13. Vasiliades J, Sahawneh T. J. Chromatogr. 1982; 228: 195.
14. Vasiliades J. J. Chromatogr. 1981; 225: 266.
15. Martens J, Banditt P. J. Chromatogr. B 1997; 692: 95.
16. Niessen WM. J. Chromatogr. A 2003; 1000: 413.
17. US Department of Health and Human Services Food and Drug Administration, Guidance for Industry: Bioanalytical Method Validation, US Department of Health and Human Services: Beltsville, MD, 2001.
18. Dadgar D, Burnett PE, Choc MG, Gallicane K, Hooper JW. J. Pharm. Biomed. Anal. 1995; 13: 89.
19. Bonfiglio R, King RC, Olah TV, Merkle K. Rapid Commun. Mass Spectrom. 1999; 13: 1175.
20. Muller C, Schafer P, Stortzel M, Vogt S, Weinmann W. J. Chromatogr. B 2002; 773: 47.
21. Hsieh Y, Chintala M, Mei H, Agans J, Brisson J-M, Ng K, et al. Rapid Commun. Mass Spectrom. 2001; 15: 2481.
22. Marquet P, Baudin O, Gaulier JM, Lacassie E, Dupuy JL, François B, Lachâtre G. J. Chromatogr. B 1999; 734: 137.
23. Lausecker B, Hopfgartner G, Hesse M. J. Chromatogr. B 1998; 718: 1.
24. Buick AR, Doig MV, Jeal SC, Land GS, McDowall RD. J. Pharm. Biomed. Anal. 1990; 8: 629.
25. Hsieh Y, Chintala M, Mei H, Agans J, Brisson JM, Ng K, Korfmacher WA. Rapid Commun. Mass Spectrom. 2001; 15: 2481.
26. Shou WZ, Naidong W. Rapid Commun. Mass Spectrom. 2003; 17: 589.
27. Schuhmacher J, Zimmer D, Tesche F, Pickard V. Rapid Commun. Mass Spectrom. 2003; 17: 1950.